Fair Allocation of Scarce CAR T-Cell Therapies for Relapsed/Refractory Multiple Myeloma | Targeted and Immune Cancer Therapy | JAMA
This Viewpoint discusses the unfairness of current CAR T-cell therapy allocation practices and offers alternative methods to more fairly allocate therapy.
Source: jamanetwork.com